VanEck Morningstar Wide M... (MVAL)
Cboe US: MVAL
· Echtzeitkurs · USD
39.62
+0.00 (0.00%)
Zum Schluss: Aug 14, 2026, 9:46 AM
VanEck Morningstar Wide Moat Value ETF (MVAL) ETF Price, Holdings & Analysis
0.00% (1D)
| Geld | 39.49 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 1.9 Mio |
| NAV | 39.43 |
| Beta | k.A. |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 20.22 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Mar 26, 2024 |
| Brief | 39.53 |
| Volumen | 9 |
| Ø Vol. (20D) | 677 |
| Eröffnung | 39.50 |
| Vortagesschluss | 39.62 |
| Tagesspanne | 39.62 - 39.67 |
| 52-Wk Range | 33.53 - 39.67 |
| Positionen | k.A. |
| Kostenquote | 0.50% |
Über MVAL
The fund invests at least 80% of its total assets in securities that comprise the fund’s benchmark index. The index is comprised of equity securities of companies that Morningstar, Inc. determines have sustainable competitive advantages based on a proprietary methodology that considers quantitative and qualitative factors and are attractively priced and weighted according to a modified equal weighting scheme that tilts exposure in favor of pure value companies. It is non-diversified.
Anlageklasse Equity
Tickersymbol MVAL
Auflagedatum Mar 26, 2024
Anbieter Vaneck
Website Fonds-Homepage
Börse Cboe US
Top Sektoren
| Sektor | Gewicht % |
|---|---|
| Consumer Defensive | 27.44% |
| Healthcare | 24.21% |
| Industrials | 12.95% |
| Consumer Cyclical | 12.59% |
| Financial Services | 10.38% |
Top 10 Positionen 39.75% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Bristol-myers Squibb... | BMY | 4.73% |
| Brown-forman Corp Re... | BF-B | 4.67% |
| Kenvue Inc | KVUE | 4.53% |
| Zimmer Biomet Holdin... | ZBH | 4.39% |
| Danaher Corp | DHR | 4.29% |
| Clorox Co | CLX | 3.87% |
| Constellation Brands... | STZ | 3.75% |
| Ge Healthcare Techno... | GEHC | 3.67% |
| Microsoft Corp | MSFT | 2.95% |
| Nike Inc Class B | NKE | 2.90% |
Dividenden Dividendenrendite 2.39%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 22, 2025 | $0.6330 | k.A. |
| Dec 23, 2024 | $0.3130 | k.A. |
